Nature Medicine
4, 506 (1998)
doi:10.1038/nm0598supp-506
Vaccine production in russia : An updateKristina S. Westerdahl
& Roger RoffeyDefence Research Establishment, Division of NBC Defence, SE-901 82 Umeå, Sweden The fall of the Soviet Union has brought about vaccine shortages and a decline in vaccine quality in Russia; improvements will require foreign investment to update production facilities.
REFERENCES
- Novikov, A., Trofimova, E. & Getman, M. Current state of the pharmaceutical industry in Russia. In The Russian Pharmaceutical Market Cuide. (ed. Bailey, M.) pages 21−108 (PJB Publications, Richmond, 1997).
- Manufacturing facility for diphtheria, tetanus and pertussis vaccine and oral polio vaccine. Lederele-Praxis Biologicals, Division of American Cyanamid Company (Wayne, New Jersey). NIS Feasibility Study prepared for U.S. Agency for International Development. Document reference PJ-ABQ-287 (1993).
- Barry, J. Planning a plague? Newsweek 1, 40−41 (1993).
- Leitenberg, M. The conversion of biological warfare research. In Control of dual threat agents: The Vaccines for Peace Programme (eds. Geissler, E. & Woodall, J.P.) 77−105 (Oxford University Press, Oxford, 1994).
|
